Table 1 Patient characteristics
Mean ± SD (n) / n/N (%) | |
|---|---|
Age [years] | 85.4 ± 2.9 (n = 71) |
Gender [female] | 44/71 (62.0) |
BMI [kg/m2] | 24.7 ± 3.7 (n = 71) |
Comorbidities | |
Hypertension | 59/71 (83.1) |
Diabetes mellitus | 19/71 (26.8) |
PAD | 20/71 (28.2) |
Prior stroke/TIA | 6/71 (8.5) |
CAD | 38/71 (53.5) |
Prior MI | 17/71 (23.9) |
Pulmonary diseasea | 11/71 (15.5) |
Pulmonary hypertension | 35/71 (49.3) |
Creatinine ≥2.0 mg/dlb | 5/71 (7.0) |
Dialysis | 2/71 (2.8) |
Prior cardiovascular intervention | |
PCI | 16/71 (22.5) |
CABG | 13/71 (18.3) |
Mitral valve replacement | 2/71 (2.8) |
Tricuspid valve replacement | 0/71 (0) |
Balloon aortic valvuloplasty | 6/71 (8.5) |
PPI | 5/71 (7.0) |
Surgical risk | |
Log EuroSCORE I | 22.5 ± 13.2 (n = 71) |
STS risk score | 5.8 ± 3.9 (n = 71) |
AS-related symptoms (%) | |
Syncope | 5/71 (7.0) |
Dizziness with exertion | 5/71 (7.0) |
CCS angina grade | |
Class III | 7/70 (10.0) |
Class IV | 0/70 (0) |
NYHA classification | |
Class III | 50/71 (70.4) |
Class IV | 7/71 (9.9) |
AS echocardiographic parameters | |
AV peak gradient (mmHg) | 78.5 ± 17.8 (n = 59) |
AV mean gradient (mmHg) | 50.5 ± 14.1 (n = 61) |
Vmax (m/s) | 4.2 ± 0.9 (n = 24) |
Effective orifice area (cm2) | 0.9 ± 0.6 (n = 37) |
LVEF (%) | 50.9 ± 12.0 (n = 62) |